PRC Clinical Selected as CRO to Conduct Critical North American Phase IIb Clinical Trial
SAN FRANCISCO--(BUSINESS WIRE)--PRC Clinical™, a Contract Research Organization (CRO) in the San Francisco Bay Area providing full-service clinical trial management services, announced today that it has been awarded a Phase IIb study in an orphan-status therapeutic indication. Enrollment is expected at more than 50 study centers in the US and Canada.